Accessing Medicinal Cannabis in Australia Patients...ACCESSING MEDICINAL CANNABIS IN AUSTRALIA...
2
ACCESSING MEDICINAL CANNABIS IN AUSTRALIA zelira About Zelira Zelira Therapeutics is a leading global biopharmaceutical company developing and marketing customised medicines uniquely formulated to target unmet patient needs. Zelira Therapeutics has developed several pharmaceutical-grade cannabinoid-based medicines that are currently available in Australia and the USA. We are committed to research and clinical development including: Medicinal Cannabis is a Prescription Medicine Medicinal cannabis is available to patients like other prescription medicines, on written authorisation from a registered medical professional. Any registered medical doctor in Australia can prescribe medicinal cannabis, if the doctor makes an evidence-based judgement that this is the appropriate treatment for their patient. The doctor will consider the patient's symptoms, family history, and the other treatments that have been tried, in making this judgement. Like any other prescription, Zelira's medicines can be dispensed by any pharmacy Australia-wide, with delivery available to most Australian locations within 24 hours. We suggest the following steps: The first step to access medicinal cannabis treatment is to discuss with your primary doctor. Some doctors are already authorised prescribers of medicinal cannabis or familiar with the Special Access Scheme pathway. If your doctor would like more information on how to prescribe or become an authorised prescriber please contact Zelira Therapeutics on 1300-ZELIRA or email [email protected] Discuss with your Doctor It may be helpful if you can find research or evidence of clinical studies relevant to your condition prior to visiting your doctor. You can find up to date information about medicinal cannabis on the TGA website www.tga.gov.au/medicinal-cannabis-guidanc e-documents Provide Supporting Evidence Ask your doctor to contact Zelira Therapeutics on 1300-ZELIRA or email [email protected] and we can help provide them with the relevant information and support to prescribe our medicines. Your doctor can also login to the ”Doctors” portal of our website to access information targeted for health care professionals. Contact Zelira Therapeutics 1 2 3 Investment in areas of unmet patient need (autism and insomnia) clinical validation of our medicines clinical trials program to satisfy regulatory requirements. Pharmaceutical grade medicines manufactured to the highest quality standards
Transcript of Accessing Medicinal Cannabis in Australia Patients...ACCESSING MEDICINAL CANNABIS IN AUSTRALIA...
ACCESSING MEDICINAL
CANNABIS IN AUSTRALIA
zelira
About ZeliraZelira Therapeutics is a leading global biopharmaceutical company developing and marketing customised medicines uniquely formulated to target unmet patient needs.
Zelira Therapeutics has developed several pharmaceutical-grade cannabinoid-based medicines that are currently available in Australia and the USA.
We are committed to research and clinical development including:
Medicinal Cannabis is a Prescription MedicineMedicinal cannabis is available to patients like other prescription medicines, on written authorisation from a registered medical professional.
Any registered medical doctor in Australia can prescribe medicinal cannabis, if the doctor makes an evidence-based judgement that this is the appropriate treatment for their patient. The doctor will consider the patient's symptoms, family history, and the other treatments that have been tried, in making this judgement.
Like any other prescription, Zelira's medicines can be dispensed by any pharmacy Australia-wide, with delivery available to most Australian locations within 24 hours.
We suggest the following steps:
The first step to access medicinal cannabis treatment is to discuss with your primary doctor. Some doctors are already authorised prescribers of medicinal cannabis or familiar with the Special Access Scheme pathway. If your doctor would like more information on how to prescribe or become an authorised prescriber please contact Zelira Therapeutics on 1300-ZELIRA or email [email protected]
Discuss with your Doctor
It may be helpful if you can find research or evidence of clinical studies relevant to your condition prior to visiting your doctor. You can find up to date information about medicinal cannabis on the TGA website www.tga.gov.au/medicinal-cannabis-guidance-documents
Provide Supporting Evidence
Ask your doctor to contact Zelira Therapeutics on 1300-ZELIRA or email [email protected] and we can help provide them with the relevant information and support to prescribe our medicines. Your doctor can also login to the ”Doctors” portal of our website to access information targeted for health care professionals.
Contact Zelira Therapeutics
1
2
3
Investment in areas of unmet patient need (autism and insomnia)clinical validation of our medicinesclinical trials program to satisfy regulatory requirements.Pharmaceutical grade medicines manufactured to the highest quality standards
DOCTOR FACTSHEETInformation to provide to your doctorZelira Therapeutics is a leading global biopharmaceutical company developing and marketing customised medicines uniquely formulated to target unmet patient needs.
Zelira Therapeutics has developed several pharmaceutical-grade cannabinoid-based medicines that are currently available in Australia and the USA.
We are committed to research and clinical development including:
Our team can contact youPlease complete this section and email to us if you’d like our Medical Team to get in touch.
Medicinal Cannabis Prescriptions
DOCTOR NAME
PRACTICE NAME
STATE
CONTACT NUMBER
References:1. https://www.tga.gov.au/access-medicinal-cannabis-products-1 (1 Sept 2020)2. Senate inquiry into the current barriers to patient access to medicinal cannabis in Australia (January 2020)
zelira
In Australia the number of medical practitioners prescribing medicinal cannabis is increasing:
56KSAS category B applications approved by the TGA for medicinal cannabis products (at 31 July 2020)1
+130 Medical conditions approved through the SAS B process2
1,4K Medical practitioners have gained approval to prescribe Medicinal Cannabis2
94 Authorised Prescribers for medicinal Cannabis in Australia (at 31 July 2020)1
Investment in areas of unmet patient need (autism and insomnia)clinical validation of our medicinesclinical trials program to satisfy regulatory requirements.Pharmaceutical grade medicines manufactured to the highest quality standards.
Zelira has a number of products in development and is undertaking human clinical trials and partnerships with world-leading researchers and organisations.
How to prescribe?Any medical practitioner can apply for medicinal cannabis via an SAS B application – you do not have to be an Authorised Prescriber, have a special license or have a formal training.
Since the TGA have streamlined the process of SAS B applications it can take as little as 10-15 minutes to apply.
Zelira has developed a step-by-step guide to assist doctors with the application process. The guide can be accessed in the “Doctors” portal of our website or to speak to one of Zelira's dedicated staff just use the phone number below during business hours.
For more information1300-ZELIRA
(1300 935 472)
www.zeliratx.com
